Metraipolis › archive › dc_c5b4ef59b5ef

Case Report: Tail-of-the-curve advantage from immune checkpoint inhibitor-anti-VEGF combination therapy: extended survival in a patient with metastatic lung… — Europe PMC PMID:41458510

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41458510
DOI
10.3389/fmed.2025.1714486
License (as archived)
solo-consultazione
Archived
2026-11-07T16:53:27.602Z
SHA-256 of the archived text
5cb27b30dafec10fc5a69bc03ba22c4c71b4faf7ea0361f7a84efb06e25a2603
Stable URL of this page
https://metraipolis.com/documento/dc_c5b4ef59b5ef

How to cite

Case Report: Tail-of-the-curve advantage from immune checkpoint inhibitor-anti-VEGF combination therapy: extended survival in a patient with metastatic lung… — Europe PMC PMID:41458510 — Europe PMC (en), https://europepmc.org/article/MED/41458510 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c5b4ef59b5ef (Metraipolis archive dc_c5b4ef59b5ef, sha256 5cb27b30dafec10fc5a69bc03ba22c4c71b4faf7ea0361f7a84efb06e25a2603)
BibTeX
@misc{dcc5b4ef59b5ef,
  title = {Case Report: Tail-of-the-curve advantage from immune checkpoint inhibitor-anti-VEGF combination therapy: extended survival in a patient with metastatic lung… — Europe PMC PMID:41458510},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41458510},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c5b4ef59b5ef; sha256 5cb27b30dafec10fc5a69bc03ba22c4c71b4faf7ea0361f7a84efb06e25a2603},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41458510. Agents can read the archived copy with the MCP tool read_document.